Biophysical, Molecular and Proteomic Profiling of Human Retinal Organoid-Derived Exosomes.

Bioreactor Extracellular vesicles Human retinal organoids Proteomics Stem cells

Journal

Pharmaceutical research
ISSN: 1573-904X
Titre abrégé: Pharm Res
Pays: United States
ID NLM: 8406521

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 11 05 2022
accepted: 23 07 2022
medline: 26 4 2023
pubmed: 25 8 2022
entrez: 24 8 2022
Statut: ppublish

Résumé

There is a growing interest in extracellular vesicles (EVs) for ocular applications as therapeutics, biomarkers, and drug delivery vehicles. EVs secreted from mesenchymal stem cells (MSCs) have shown to provide therapeutic benefits in ocular conditions. However, very little is known about the properties of bioreactor cultured-3D human retinal organoids secreted EVs. This study provides a comprehensive morphological, nanomechanical, molecular, and proteomic characterization of retinal organoid EVs and compares it with human umbilical cord (hUC) MSCs. The morphology and nanomechanical properties of retinal organoid EVs were assessed using Nanoparticle tracking analysis (NTA) and Atomic force microscopy (AFM). Gene expression analysis of exosome biogenesis of early and late retinal organoids were compared using qPCR. The protein profile of the EVs were analyzed with proteomic tools. NTA indicated the average size of EV as 100-250 nm. A high expression of exosome biogenesis genes was observed in late retinal organoids EVs. Immunoblot analysis showed highly expressed exosomal markers in late retinal organoids EVs compared to early retinal organoids EVs. Protein profiling of retinal organoid EVs displayed a higher differential expression of retinal function-related proteins and EV biogenesis proteins than hUCMSC EVs, implicating that the use of retinal organoid EVs may have a superior therapeutic effect on retinal disorders. This study provides supplementary knowledge on the properties of retinal organoid EVs and suggests their potential use in the diagnostic and therapeutic treatments for ocular diseases.

Identifiants

pubmed: 36002615
doi: 10.1007/s11095-022-03350-7
pii: 10.1007/s11095-022-03350-7
pmc: PMC10576571
mid: NIHMS1835060
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

801-816

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS125016
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD007582
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY032197
Pays : United States
Organisme : NEI NIH HHS
ID : U24 EY029891
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA015083
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL105826
Pays : United States
Organisme : NIH HHS
ID : U24 EY029891
Pays : United States
Organisme : NIH HHS
ID : R01-NS125016
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY002162
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA102701
Pays : United States
Organisme : NIH HHS
ID : R01- EY032197
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Tissue Eng Part B Rev. 2020 Apr;26(2):129-144
pubmed: 31847715
Sci Rep. 2016 Apr 12;6:23978
pubmed: 27068479
Nat Rev Nephrol. 2017 Dec;13(12):731-749
pubmed: 29081510
Nat Commun. 2014 Sep 10;5:4889
pubmed: 25205175
Cell Stem Cell. 2016 Jun 2;18(6):769-781
pubmed: 27151457
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Mol Ther Nucleic Acids. 2019 Jun 7;16:778-790
pubmed: 31163320
PLoS One. 2011 Feb 10;6(2):e17084
pubmed: 21347327
Expert Rev Ophthalmol. 2013 Jun 1;8(3):213-216
pubmed: 24039627
Sci Rep. 2016 Sep 30;6:34562
pubmed: 27686625
J Cell Mol Med. 2016 Aug;20(8):1457-66
pubmed: 26999719
Stem Cells. 2019 May;37(5):593-598
pubmed: 30548510
J Cell Biochem. 2017 Dec;118(12):4267-4274
pubmed: 28422319
Cell Death Differ. 2021 Mar;28(3):1041-1061
pubmed: 33082517
Stem Cells Transl Med. 2017 Apr;6(4):1273-1285
pubmed: 28198592
Crit Rev Ther Drug Carrier Syst. 2021;38(3):1-31
pubmed: 34348017
Stem Cells. 2019 May;37(5):609-622
pubmed: 30681766
Prog Retin Eye Res. 2020 Mar;75:100779
pubmed: 31494256
Stem Cells Transl Med. 2017 Aug;6(8):1730-1739
pubmed: 28714557
PLoS One. 2018 Feb 7;13(2):e0191109
pubmed: 29415026
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):13087-13096
pubmed: 31189593
Biochim Biophys Acta Gen Subj. 2019 May;1863(5):802-812
pubmed: 30763604
Front Pharmacol. 2021 Nov 29;12:748956
pubmed: 34912217
Stem Cell Reports. 2021 Nov 9;16(11):2690-2702
pubmed: 34653402
Curr Gene Ther. 2013 Apr;13(2):139-51
pubmed: 23320477
Prog Retin Eye Res. 2017 Jul;59:158-177
pubmed: 28465248
Curr Opin Ophthalmol. 2008 May;19(3):255-62
pubmed: 18408503
Sci Rep. 2017 Jun 28;7(1):4323
pubmed: 28659587
Nanoscale. 2018 Dec 7;10(45):20930-20945
pubmed: 30406223
Front Biosci (Landmark Ed). 2022 Mar 8;27(3):86
pubmed: 35345318
Cells. 2019 Jul 15;8(7):
pubmed: 31311206
J Extracell Vesicles. 2014 Mar 25;3:
pubmed: 24678386
Stem Cells Transl Med. 2018 Feb;7(2):210-219
pubmed: 29266841
Theranostics. 2018 Jan 1;8(1):237-255
pubmed: 29290805
Cells. 2019 Aug 28;8(9):
pubmed: 31466320
Adv Sci (Weinh). 2018 Dec 20;6(4):1800948
pubmed: 30828519
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
Scanning. 2010 Mar-Apr;32(2):61-73
pubmed: 20695025
Development. 2019 Jan 9;146(1):
pubmed: 30567931
Nat Commun. 2018 Oct 12;9(1):4234
pubmed: 30315276
Sci Rep. 2015 Mar 17;5:9205
pubmed: 25777362
Mol Ther. 2018 Dec 5;26(12):2838-2847
pubmed: 30341012
Invest Ophthalmol Vis Sci. 1999 Nov;40(12):2795-802
pubmed: 10549638
Neurotherapeutics. 2011 Oct;8(4):736-43
pubmed: 21948217
World J Stem Cells. 2020 Mar 26;12(3):178-187
pubmed: 32266050
J Biol Chem. 2013 Sep 27;288(39):28058-67
pubmed: 23926109
Int J Pharm. 2021 Sep 25;607:120943
pubmed: 34324983
Cell Death Differ. 2008 Jan;15(1):183-91
pubmed: 17932498
Lancet. 2006 Nov 18;368(9549):1795-809
pubmed: 17113430
Sci Rep. 2021 Oct 26;11(1):21128
pubmed: 34702879
Sci Rep. 2018 Sep 28;8(1):14520
pubmed: 30266927
J Ophthalmic Vis Res. 2013 Apr;8(2):147-59
pubmed: 23943690
Science. 2018 Oct 12;362(6411):
pubmed: 30309916
J Cell Mol Med. 2020 Jul;24(13):7515-7530
pubmed: 32424968
J Proteome Res. 2014 Feb 7;13(2):581-95
pubmed: 24400796
PLoS Pathog. 2020 Dec 31;16(12):e1009023
pubmed: 33382850
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
Methods Mol Biol. 2013;931:295-312
pubmed: 23027008
Stem Cell Rev Rep. 2021 Aug;17(4):1154-1173
pubmed: 33410097
Int J Nanomedicine. 2012;7:1525-41
pubmed: 22619510
Biomaterials. 2018 Feb;156:16-27
pubmed: 29182933
Stem Cell Res Ther. 2021 Jan 13;12(1):55
pubmed: 33436078
J Extracell Vesicles. 2021 Nov;10(13):e12165
pubmed: 34750957
J Nanobiotechnology. 2022 Feb 8;20(1):74
pubmed: 35135558
J Virol. 2017 Feb 14;91(5):
pubmed: 27974566
Life Sci. 2020 Nov 15;261:118369
pubmed: 32882265
Stem Cells. 2018 Oct;36(10):1535-1551
pubmed: 30004612
Cell Rep. 2020 Feb 4;30(5):1644-1659.e4
pubmed: 32023475

Auteurs

Peggy Arthur (P)

College of Pharmacy and Pharmacological Sciences, Florida A&M University, Tallahassee, FL, USA.

Sangeetha Kandoi (S)

Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA.
Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, USA.

Li Sun (L)

Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL, USA.
Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL, USA.

Anil Kalvala (A)

College of Pharmacy and Pharmacological Sciences, Florida A&M University, Tallahassee, FL, USA.

Shallu Kutlehria (S)

College of Pharmacy and Pharmacological Sciences, Florida A&M University, Tallahassee, FL, USA.

Santanu Bhattacharya (S)

Department of Biochemistry and Molecular Biology, Mayo College of Medicine and Science, Jacksonville, FL, USA.
Department of Physiology and Biomedical Engineering, Mayo College of Medicine and Science, Jacksonville, FL, USA.

Tanmay Kulkarni (T)

Department of Biochemistry and Molecular Biology, Mayo College of Medicine and Science, Jacksonville, FL, USA.

Ramesh Nimma (R)

College of Pharmacy and Pharmacological Sciences, Florida A&M University, Tallahassee, FL, USA.

Yan Li (Y)

Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL, USA. yli@eng.famu.fsu.edu.

Deepak A Lamba (DA)

Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA. deepak.lamba@ucsf.edu.

Mandip Singh (M)

College of Pharmacy and Pharmacological Sciences, Florida A&M University, Tallahassee, FL, USA. mandip.sachdeva@famu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH